CCL2 and cancer: Here, we demonstrated that repeated i.t. injection of INCB3344 exerted anti-allodynic effects, as previously observed in neuropathic, postoperative, and cancer-induced bone pain models using anti-CCL2 antibodies or small molecule antagonists of CCR2 [15, 84–91].